Sheaniva H. Murray
Sheaniva Murray represents clients in response to government actions, investigations, and litigation related to claims brought under various federal and state regulations. In addition, Sheaniva regularly counsels healthcare companies on fraud and abuse matters related to alleged violations under the False Claims Act (FCA), Anti-Kickback Statute (AKS), the Stark Law and Medicare and Medicaid reimbursement rules.
Prior to joining Bass, Berry & Sims, Sheaniva was a legal fellow in the Office of General Counsel at Inova Health System. In this capacity, Sheaniva researched federal and state regulations affecting health systems and providers related to reimbursement, data privacy, licensing and certification, and operational compliance. Prior to and during law school, Sheaniva worked in government affairs. Her background in policy and work with healthcare providers, patients, and health systems informs her approach on compliance matters and government investigations.
Sheaniva earned a law degree from Georgetown University Law Center, an M.A. in political management from The George Washington University, and a B.A. in liberal arts from The Harriet L. Wilkes Honors College of Florida Atlantic University.
Memberships
District of Columbia Bar Association
Maryland State Bar Association
American Health Law Association (AHLA)
American Bar Association (ABA)
Representative Experience
-
Read More
Representation of a national healthcare company in an investigation related to allegations of fraudulent risk adjustment coding practices. Matter involved government disclosure and an analysis of data correction obligations.
-
Read More
Representation of a Medicare Advantage Organization and its wholly-owned provider group in an internal investigation related to allegations of improper coding practices, hostile work environment, and non-compliance with Medicare requirements.
-
Read More
Representation of Consonance Capital, a private equity manager focused exclusively on the healthcare industry, in their recapitalization of Orsini Pharmaceutical Services, a leading nationwide specialty pharmaceutical provider. Terms of the transaction were not disclosed.
Publications
Media Mentions & Firm News
Accolades
Lawyers of Color — Hot List (2022)
Food and Drug Law Journal — Student Senior Staff Editor (2016-2017)
